Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Agilon Health Inc has a consensus price target of $8.57 based on the ratings of 28 analysts. The high is $33 issued by Truist Securities on July 14, 2022. The low is $2 issued by TD Cowen on November 11, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, Barclays, and Goldman Sachs on May 13, 2025, May 8, 2025, and May 8, 2025, respectively. With an average price target of $4.33 between Wells Fargo, Barclays, and Goldman Sachs, there's an implied 95.20% upside for Agilon Health Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/13/2025 | Buy Now | 125.23% | Wells Fargo | Stephen Baxter54% | $6 → $5 | Maintains | Overweight | Get Alert |
05/08/2025 | Buy Now | 35.14% | Barclays | Andrew Mok58% | $2 → $3 | Maintains | Underweight | Get Alert |
05/08/2025 | Buy Now | 125.23% | Goldman Sachs | Jamie Perse63% | $2.5 → $5 | Maintains | Neutral | Get Alert |
04/28/2025 | Buy Now | — | JMP Securities | Constantine Davides41% | — | Reiterates | Market Perform → Market Perform | Get Alert |
04/25/2025 | Buy Now | 125.23% | Citigroup | Daniel Grosslight39% | $3.25 → $5 | Upgrade | Neutral → Buy | Get Alert |
04/15/2025 | Buy Now | 170.27% | TD Cowen | Ryan Langston27% | $3.5 → $6 | Maintains | Hold | Get Alert |
04/15/2025 | Buy Now | 125.23% | Baird | Michael Halloran67% | $6 → $5 | Maintains | Neutral | Get Alert |
04/08/2025 | Buy Now | 282.88% | Bernstein | Amir Farahan 2% | $3.3 → $8.5 | Upgrade | Market Perform → Outperform | Get Alert |
03/21/2025 | Buy Now | — | Needham | Ryan MacDonald62% | — | Reiterates | Hold → Hold | Get Alert |
02/26/2025 | Buy Now | 57.66% | RBC Capital | Sean Dodge46% | $3 → $3.5 | Maintains | Outperform | Get Alert |
02/26/2025 | Buy Now | — | Citizens Capital Markets | Constantine Davides41% | — | Reiterates | Market Perform → Market Perform | Get Alert |
02/26/2025 | Buy Now | 35.14% | Stifel | Craig Jones55% | $2 → $3 | Maintains | Hold | Get Alert |
02/26/2025 | Buy Now | — | Needham | Ryan MacDonald62% | — | Reiterates | Hold → Hold | Get Alert |
01/15/2025 | Buy Now | 41.89% | Bernstein | Amir Farahan 2% | $2.5 → $3.15 | Maintains | Market Perform | Get Alert |
01/10/2025 | Buy Now | 1.35% | Citigroup | Daniel Grosslight39% | $1.75 → $2.25 | Upgrade | Sell → Neutral | Get Alert |
01/10/2025 | Buy Now | — | Needham | Matthew Sheerin73% | — | Reiterates | Hold → Hold | Get Alert |
12/16/2024 | Buy Now | 35.14% | Macquarie | Tao Qiu51% | → $3 | Initiates | → Neutral | Get Alert |
12/11/2024 | Buy Now | 12.61% | Bernstein | Lance Wilkes61% | → $2.5 | Initiates | → Market Perform | Get Alert |
11/19/2024 | Buy Now | 35.14% | RBC Capital | Sean Dodge46% | $3 → $3 | Reiterates | Outperform → Outperform | Get Alert |
11/13/2024 | Buy Now | -21.17% | Citigroup | Daniel Grosslight39% | $2.5 → $1.75 | Maintains | Sell | Get Alert |
11/12/2024 | Buy Now | -9.91% | Stifel | Craig Jones55% | $7 → $2 | Maintains | Hold | Get Alert |
11/11/2024 | Buy Now | -9.91% | TD Cowen | Gary Taylor59% | $6 → $2 | Maintains | Hold | Get Alert |
11/11/2024 | Buy Now | -9.91% | Barclays | Andrew Mok58% | $5 → $2 | Maintains | Underweight | Get Alert |
11/11/2024 | Buy Now | — | JMP Securities | Constantine Davides41% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
11/08/2024 | Buy Now | — | William Blair | Ryan Daniels20% | — | Downgrade | Outperform → Market Perform | Get Alert |
10/29/2024 | Buy Now | 12.61% | Citigroup | Daniel Grosslight39% | $7 → $2.5 | Downgrade | Neutral → Sell | Get Alert |
10/08/2024 | Buy Now | 80.18% | Evercore ISI Group | Elizabeth Anderson46% | $7 → $4 | Maintains | In-Line | Get Alert |
10/02/2024 | Buy Now | 35.14% | B of A Securities | Kevin Fischbeck67% | → $3 | Downgrade | Buy → Underperform | Get Alert |
08/09/2024 | Buy Now | 80.18% | Deutsche Bank | George Hill61% | $5 → $4 | Maintains | Hold | Get Alert |
08/08/2024 | Buy Now | 305.41% | Benchmark | Bill Sutherland68% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
08/07/2024 | Buy Now | 260.36% | RBC Capital | Sean Dodge46% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
07/09/2024 | Buy Now | 215.32% | Evercore ISI Group | Elizabeth Anderson46% | $5.5 → $7 | Maintains | In-Line | Get Alert |
05/30/2024 | Buy Now | 170.27% | Baird | Michael Halloran67% | → $6 | Initiates | → Neutral | Get Alert |
05/24/2024 | Buy Now | 192.79% | Truist Securities | Jailendra Singh36% | $6.4 → $6.5 | Maintains | Hold | Get Alert |
05/01/2024 | Buy Now | 215.32% | Stifel | Craig Jones55% | $8 → $7 | Maintains | Hold | Get Alert |
04/22/2024 | Buy Now | 170.27% | Citigroup | Daniel Grosslight39% | → $6 | Initiates | → Neutral | Get Alert |
04/15/2024 | Buy Now | 188.29% | Truist Securities | Jailendra Singh36% | $7.5 → $6.4 | Maintains | Hold | Get Alert |
03/06/2024 | Buy Now | 125.23% | Barclays | Andrew Mok58% | → $5 | Initiates | → Underweight | Get Alert |
02/29/2024 | Buy Now | 237.84% | Truist Securities | Jailendra Singh36% | $10 → $7.5 | Maintains | Hold | Get Alert |
02/29/2024 | Buy Now | 305.41% | Benchmark | Bill Sutherland68% | $13 → $9 | Maintains | Buy | Get Alert |
02/28/2024 | Buy Now | 170.27% | Evercore ISI Group | Elizabeth Anderson46% | $7 → $6 | Maintains | In-Line | Get Alert |
02/28/2024 | Buy Now | 260.36% | RBC Capital | Sean Dodge46% | $11 → $8 | Maintains | Outperform | Get Alert |
02/26/2024 | Buy Now | 260.36% | Wells Fargo | Stephen Baxter54% | $16 → $8 | Maintains | Overweight | Get Alert |
02/26/2024 | Buy Now | 192.79% | TD Cowen | Gary Taylor59% | $12 → $6.5 | Downgrade | Outperform → Market Perform | Get Alert |
02/22/2024 | Buy Now | 305.41% | Stifel | Craig Jones55% | $10 → $9 | Maintains | Hold | Get Alert |
01/08/2024 | Buy Now | — | Wolfe Research | Justin Lake31% | — | Downgrade | Outperform → Peer Perform | Get Alert |
01/05/2024 | Buy Now | 350.45% | Truist Securities | Jailendra Singh36% | $23 → $10 | Downgrade | Buy → Hold | Get Alert |
01/05/2024 | Buy Now | 305.41% | JP Morgan | Lisa Gill56% | $17 → $9 | Downgrade | Overweight → Neutral | Get Alert |
12/13/2023 | Buy Now | 665.77% | JP Morgan | Lisa Gill56% | $36 → $17 | Maintains | Overweight | Get Alert |
12/11/2023 | Buy Now | — | Goldman Sachs | Jamie Perse63% | — | Downgrade | Buy → Neutral | Get Alert |
12/06/2023 | Buy Now | 710.81% | JMP Securities | Constantine Davides41% | → $18 | Initiates | → Market Outperform | Get Alert |
11/21/2023 | Buy Now | 440.54% | Deutsche Bank | George Hill61% | $27 → $12 | Downgrade | Buy → Hold | Get Alert |
11/15/2023 | Buy Now | 890.99% | Benchmark | Bill Sutherland68% | $28 → $22 | Maintains | Buy | Get Alert |
11/13/2023 | Buy Now | 620.72% | Wells Fargo | Stephen Baxter54% | $23 → $16 | Maintains | Overweight | Get Alert |
11/09/2023 | Buy Now | 936.04% | Truist Securities | Jailendra Singh36% | $27 → $23 | Maintains | Buy | Get Alert |
11/09/2023 | Buy Now | 890.99% | Goldman Sachs | Jamie Perse63% | $25 → $22 | Maintains | Buy | Get Alert |
11/03/2023 | Buy Now | 936.04% | RBC Capital | Sean Dodge46% | $28 → $23 | Maintains | Outperform | Get Alert |
10/20/2023 | Buy Now | 1161.26% | Benchmark | Bill Sutherland68% | → $28 | Initiates | → Buy | Get Alert |
08/15/2023 | Buy Now | 1026.13% | Goldman Sachs | Jamie Perse63% | $29 → $25 | Maintains | Buy | Get Alert |
08/15/2023 | Buy Now | 1026.13% | TD Cowen | Gary Taylor59% | $29 → $25 | Maintains | Outperform | Get Alert |
06/20/2023 | Buy Now | 1116.22% | Truist Securities | Jailendra Singh36% | $35 → $27 | Maintains | Buy | Get Alert |
06/13/2023 | Buy Now | 913.51% | Evercore ISI Group | Elizabeth Anderson46% | → $22.5 | Initiates | → In-Line | Get Alert |
05/31/2023 | Buy Now | 1206.31% | Goldman Sachs | Jamie Perse63% | $32 → $29 | Maintains | Buy | Get Alert |
05/15/2023 | Buy Now | 1116.22% | Deutsche Bank | George Hill61% | $28 → $27 | Maintains | Buy | Get Alert |
05/10/2023 | Buy Now | 1386.49% | RBC Capital | Sean Dodge46% | → $33 | Reiterates | → Outperform | Get Alert |
05/10/2023 | Buy Now | 1341.44% | Stifel | Craig Jones55% | $29 → $32 | Maintains | Buy | Get Alert |
04/17/2023 | Buy Now | 1476.58% | Truist Securities | Jailendra Singh36% | $29 → $35 | Maintains | Buy | Get Alert |
03/06/2023 | Buy Now | 1251.35% | Guggenheim | Sandy Draper73% | $21 → $30 | Maintains | Buy | Get Alert |
03/03/2023 | Buy Now | 1161.26% | Deutsche Bank | George Hill61% | $26 → $28 | Maintains | Buy | Get Alert |
12/09/2022 | Buy Now | 936.04% | Stifel | Craig Jones55% | → $23 | Initiates | → Buy | Get Alert |
11/15/2022 | Buy Now | 1431.53% | Goldman Sachs | Jamie Perse63% | $38 → $34 | Maintains | Buy | Get Alert |
11/15/2022 | Buy Now | 890.99% | Wells Fargo | Stephen Baxter54% | $28 → $22 | Maintains | Overweight | Get Alert |
11/04/2022 | Buy Now | 1251.35% | SVB Leerink | Whit Mayo66% | $33 → $30 | Maintains | Outperform | Get Alert |
09/14/2022 | Buy Now | 1386.49% | RBC Capital | Sean Dodge46% | → $33 | Initiates | → Outperform | Get Alert |
09/12/2022 | Buy Now | 1611.71% | Goldman Sachs | Jamie Perse63% | → $38 | Initiates | → Buy | Get Alert |
09/07/2022 | Buy Now | 1206.31% | Truist Securities | Jailendra Singh36% | $33 → $29 | Assumes | → Buy | Get Alert |
08/08/2022 | Buy Now | 1161.26% | Wells Fargo | Stephen Baxter54% | $23 → $28 | Maintains | Overweight | Get Alert |
08/03/2022 | Buy Now | 1251.35% | Deutsche Bank | George Hill61% | $29 → $30 | Maintains | Buy | Get Alert |
07/14/2022 | Buy Now | 1386.49% | Truist Securities | David Macdonald66% | $30 → $33 | Maintains | Buy | Get Alert |
06/24/2022 | Buy Now | — | BTIG | David Larsen46% | — | Initiates | → Neutral | Get Alert |
06/08/2022 | Buy Now | 1071.17% | Deutsche Bank | George Hill61% | $26 → $26 | Maintains | Buy | Get Alert |
The latest price target for Agilon Health (NYSE:AGL) was reported by Wells Fargo on May 13, 2025. The analyst firm set a price target for $5.00 expecting AGL to rise to within 12 months (a possible 125.23% upside). 33 analyst firms have reported ratings in the last year.
The latest analyst rating for Agilon Health (NYSE:AGL) was provided by Wells Fargo, and Agilon Health maintained their overweight rating.
The last upgrade for Agilon Health Inc happened on April 25, 2025 when Citigroup raised their price target to $5. Citigroup previously had a neutral for Agilon Health Inc.
The last downgrade for Agilon Health Inc happened on November 11, 2024 when JMP Securities changed their price target from N/A to N/A for Agilon Health Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on May 13, 2025 so you should expect the next rating to be made available sometime around May 13, 2026.
While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $6.00 to $5.00. The current price Agilon Health (AGL) is trading at is $2.22, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.